Purmx Therapeutics is a pharmaceutical company that develops RNA nucleic acid medicine for therapeutic effects on intractable diseases.
Purmx Therapeutics's investors include Mitsubishi UFJ Capital, UTEC - The University of Tokyo Edge Capital Partners, Johnson & Johnson Innovation, Osaka University Venture Capital, Hiroshima Venture Capital.
Purmx Therapeutics is headquartered in Hiroshima, Japan.
Purmx Therapeutics is a pharmaceutical company that develops RNA nucleic acid medicine for therapeutic effects on intractable diseases.
Purmx Therapeutics is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Purmx Therapeutics — Funding & Investors." VCBacked, June 25, 2025, https://www.vcbacked.co/company/purmx-therapeutics. Accessed September 30, 2026.
VCBacked. (2025). Purmx Therapeutics — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/purmx-therapeutics
{{cite web |title=Purmx Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/purmx-therapeutics |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated